Functional characterization of human cancer-derived TRKB mutations. - Wikidata - wikimedia - TriplyDB

Functional characterization of human cancer-derived TRKB mutations.

Functional characterization of human cancer-derived TRKB mutations.

http://www.wikidata.org/entity/Q33838325

about

TRKing down an old oncogene in a new era of targeted therapy A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations.Linkage analysis of extended high-risk pedigrees replicates a cutaneous malignant melanoma predisposition locus on chromosome 9q21.Cooperation of tyrosine kinase receptor TrkB and epidermal growth factor receptor signaling enhances migration and dispersal of lung tumor cells Structure-functional prediction and analysis of cancer mutation effects in protein kinases.BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations.Functional characterization of NTRK1 mutations identified in melanoma.BDNF/TrkB signaling as an anti-tumor target.

P2860

Q28254287-C1CEB919-0E06-4A3B-B359-6E8C57C05B8A Q30360645-1F0CC779-7C62-44EC-AE94-E315358F1163 Q36502322-7DCCF39E-BEEB-41E1-8657-6AF72841FA2D Q38981752-C265B34E-66F0-423A-A5CF-A4281D245B1D Q38987589-5549C952-2E0B-4E0E-BE5C-2587E7E9E866 Q41093124-91F2AA9C-0C78-481D-95AE-A40432B6D5CB Q42800660-BF649ADD-0849-4E52-8D03-F205635FC209 Q48840378-0941A950-39C0-4AEB-8BC1-9EFBC61403DC

P2860

Functional characterization of human cancer-derived TRKB mutations.

http://www.wikidata.org/entity/Q33838325

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Functional characterization of human cancer-derived TRKB mutations.

@ast

Functional characterization of human cancer-derived TRKB mutations.

@en

type

label

Functional characterization of human cancer-derived TRKB mutations.

@ast

Functional characterization of human cancer-derived TRKB mutations.

@en

prefLabel

Functional characterization of human cancer-derived TRKB mutations.

@ast

Functional characterization of human cancer-derived TRKB mutations.

@en

P1433

Q33838325-EE6C718C-7E6E-403F-9EF7-73E72DFF4DE3

P1476

Q33838325-90832B40-778B-4712-9E7C-2A483B066E76

P2093

Q33838325-2BB30F75-34E0-4E77-80AB-A80FA3AE9321

Q33838325-ACD4CF92-58CC-4E5A-A1FA-934C7F9DAF96

Q33838325-B1076C90-2E83-43E1-BF3D-A5A69E581677

Q33838325-C8AB69C1-74B2-46B4-8288-976567262EF3

P2860

Q33838325-0B6BE4E8-59B1-4B7C-9FE0-16150722EB6C

Q33838325-0CF2A81B-95F8-4DF5-8BE2-BA6D713A291C

Q33838325-118E27C3-5400-4073-BEF3-616205A7F838

Q33838325-17DCBC4B-666D-4AA4-8824-81E6D46E77A5

Q33838325-1E2AADD3-85CF-4346-A4DD-5E66C820A6CD

Q33838325-1E81114E-48C3-4FF0-81ED-C1FAD9384997

Q33838325-38267F9B-B793-467E-BA14-3B6D2C943960

Q33838325-405827E5-F16D-40BA-8C29-5B00F7A2E81E

Q33838325-472A2765-DB68-4747-8408-72C589DF6E44

Q33838325-5C0036EA-09F7-496F-A72A-398B97DE2B77

P304

Q33838325-9542EA10-C009-4D93-8F13-E64660B9D09E

P31

Q33838325-F4490EBB-BB9B-4358-89D6-848F4B52B8B9

P356

Q33838325-F36DF8C9-5300-4F17-AB3D-D02BD6B6472B

P407

Q33838325-D2E0D18E-4E31-4B4A-886C-366AB6E6BD84

P433

Q33838325-13598418-9A63-47C7-AEF4-A4C8E6A4041E

P478

Q33838325-9DD4072E-0C6F-4337-86B6-8F2412E98DE4

P577

Q33838325-BD4C01A6-8866-4621-ABCA-5BE427387330

P5875

Q33838325-61485211-3D00-4E37-A0F6-53C29688F1CD

P698

Q33838325-EDC49D71-BF68-4A34-ABFD-35623B541E33

P932

Q33838325-72E92DD2-E129-4AE4-BF69-CA3B370C1FC4

P356

JOURNAL.PONE.0016871

P1433

P1476

Functional characterization of human cancer-derived TRKB mutations.

@en

P2093

Aranzazu Rosado

http://www.w3.org/2001/XMLSchema#string

Daniel S Peeper

http://www.w3.org/2001/XMLSchema#string

Ji-Ying Song

http://www.w3.org/2001/XMLSchema#string

Thomas R Geiger

http://www.w3.org/2001/XMLSchema#string

P2860

Survival of cancer cells is maintained by EGFR independent of its kinase activity

A census of human cancer genes

Somatic mutations affect key pathways in lung adenocarcinoma

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

Mutations of the BRAF gene in human cancer

The consensus coding sequences of human breast and colorectal cancers

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Trk receptors: roles in neuronal signal transduction.

P304

e16871

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0016871

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50290357

http://www.w3.org/2001/XMLSchema#string

P698

21379385

http://www.w3.org/2001/XMLSchema#string

P932

3040757

http://www.w3.org/2001/XMLSchema#string